Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Genentech, Amgen Face Big Impact From Part B International Pricing Index

Wed, 10/31/2018 - 12:22pm

Medicare spending on Genentech’s Rituxan and Lucentis, and Amgen’s Neulasta and Prolia/Xgeva, would have been $3.8bn less in 2016 using...

      Related Stories 

Ferring's New Chief Falk Talks

Wed, 10/31/2018 - 6:31am

Ferring announced this morning (Oct. 31) that Michel Pettigrew is retiring as president of the executive board and will be...

      Related Stories 

Political Turmoil, Big Pharma Resistance Threaten Turkey's Drug Production Drive

Wed, 10/31/2018 - 6:22am

The Turkish government's drive to increase domestic production of medicines used the country has had some success for generic drugs...

      Related Stories 

Executives On The Move: Celgene Picks a Clinical Development Head And Axcella Health Gains a New CBO From Novartis

Wed, 10/31/2018 - 6:20am

At NuVasive, a new CEO is slated to take charge. Celgene chooses as President, Global Clinical Development an exec from EMD Serono and Axcella Health fills its...

      Related Stories 

Strong Innovent IPO Restoring Faith In HK Biotech Listings?

Wed, 10/31/2018 - 12:53am

Suzhou-based Innovent Bio becomes the fourth biotech from mainland China to go public in Hong Kong, and its strong first-day...

      Related Stories 

Q3 Pharma Earnings Preview: AbbVie, Lilly, AstraZeneca And Bayer

Tue, 10/30/2018 - 11:23am

AbbVie faces analysts just a couple weeks after Humira biosimilars hit the market, and with Gilead launching authorized generics of...

      Related Stories 

Darzalex Excites As Potential Grows In Multiple Myeloma

Tue, 10/30/2018 - 9:15am

Positive top-line results from the MAIA study of daratumumab as a front-line treatment for multiple myeloma highlights the future sales...

      Related Stories 

Pfizer Well-Placed To Lead First-Line Advanced RCC Market

Tue, 10/30/2018 - 8:56am

Two successful Phase III studies of Inlyta in combination with two distinct immunotherapies, including its own, Merck KGaA-partnered Bavencio, puts...

      Related Stories 

Asajes Offers Up Innovative Partnering Model For Asia Development

Tue, 10/30/2018 - 12:43am

Asajes Ventures sees itself as offering a unique new mixed business model of venture capital and local development activity for smaller...

      Related Stories 

Diabetes Drug CV Outcomes Trials May Be Needed For Market Success But Not Approval, US FDA Panel Says

Mon, 10/29/2018 - 2:30pm

Longer, broader premarketing trials should replace the requirement for dedicated outcomes trials to demonstrate CV safety, but competitive pressure may...

      Related Stories